Cargando…
Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
BACKGROUND & AIMS: Sleep disturbance is associated with the development of obesity, diabetes and hepatic steatosis in murine models. Hepatic triglyceride accumulation oscillates in a circadian rhythm regulated by clock genes, light-dark cycle and feeding time in mice. The role of the sleep-wake...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648512/ https://www.ncbi.nlm.nih.gov/pubmed/26576055 http://dx.doi.org/10.1371/journal.pone.0143293 |
_version_ | 1782401247549063168 |
---|---|
author | Bernsmeier, Christine Weisskopf, Diego M. Pflueger, Marlon O. Mosimann, Jan Campana, Benedetta Terracciano, Luigi Beglinger, Christoph Heim, Markus H. Cajochen, Christian |
author_facet | Bernsmeier, Christine Weisskopf, Diego M. Pflueger, Marlon O. Mosimann, Jan Campana, Benedetta Terracciano, Luigi Beglinger, Christoph Heim, Markus H. Cajochen, Christian |
author_sort | Bernsmeier, Christine |
collection | PubMed |
description | BACKGROUND & AIMS: Sleep disturbance is associated with the development of obesity, diabetes and hepatic steatosis in murine models. Hepatic triglyceride accumulation oscillates in a circadian rhythm regulated by clock genes, light-dark cycle and feeding time in mice. The role of the sleep-wake cycle in the pathogenesis of human non-alcoholic fatty liver disease (NAFLD) is indeterminate. We sought to detail sleep characteristics, daytime sleepiness and meal times in relation to disease severity in patients with NAFLD. METHODS: Basic Sleep duration and latency, daytime sleepiness (Epworth sleepiness scale), Pittsburgh sleep quality index, positive and negative affect scale, Munich Chronotype Questionnaire and an eating habit questionnaire were assessed in 46 patients with biopsy-proven NAFLD and 22 healthy controls, and correlated with biochemical and histological parameters. RESULTS: In NAFLD compared to healthy controls, time to fall asleep was vastly prolonged (26.9 vs. 9.8 min., p = 0.0176) and sleep duration was shortened (6.3 vs. 7.2 hours, p = 0.0149). Sleep quality was poor (Pittsburgh sleep quality index 8.2 vs. 4.7, p = 0.0074) and correlated with changes in affect. Meal frequency was shifted towards night-times (p = 0.001). In NAFLD but not controls, daytime sleepiness significantly correlated with liver enzymes (ALAT [r = 0.44, p = 0.0029], ASAT [r = 0.46, p = 0.0017]) and insulin resistance (HOMA-IR [r = 0.5, p = 0.0009]) independent of cirrhosis. In patients with fibrosis, daytime sleepiness correlated with the degree of fibrosis (r = 0.364, p = 0.019). CONCLUSIONS: In NAFLD sleep duration was shortened, sleep onset was delayed and sleep quality poor. Food-intake was shifted towards the night. Daytime sleepiness was positively linked to biochemical and histologic surrogates of disease severity. The data may indicate a role for sleep-wake cycle regulation and timing of food-intake in the pathogenesis of human NAFLD as suggested from murine models. |
format | Online Article Text |
id | pubmed-4648512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-46485122015-11-25 Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls Bernsmeier, Christine Weisskopf, Diego M. Pflueger, Marlon O. Mosimann, Jan Campana, Benedetta Terracciano, Luigi Beglinger, Christoph Heim, Markus H. Cajochen, Christian PLoS One Research Article BACKGROUND & AIMS: Sleep disturbance is associated with the development of obesity, diabetes and hepatic steatosis in murine models. Hepatic triglyceride accumulation oscillates in a circadian rhythm regulated by clock genes, light-dark cycle and feeding time in mice. The role of the sleep-wake cycle in the pathogenesis of human non-alcoholic fatty liver disease (NAFLD) is indeterminate. We sought to detail sleep characteristics, daytime sleepiness and meal times in relation to disease severity in patients with NAFLD. METHODS: Basic Sleep duration and latency, daytime sleepiness (Epworth sleepiness scale), Pittsburgh sleep quality index, positive and negative affect scale, Munich Chronotype Questionnaire and an eating habit questionnaire were assessed in 46 patients with biopsy-proven NAFLD and 22 healthy controls, and correlated with biochemical and histological parameters. RESULTS: In NAFLD compared to healthy controls, time to fall asleep was vastly prolonged (26.9 vs. 9.8 min., p = 0.0176) and sleep duration was shortened (6.3 vs. 7.2 hours, p = 0.0149). Sleep quality was poor (Pittsburgh sleep quality index 8.2 vs. 4.7, p = 0.0074) and correlated with changes in affect. Meal frequency was shifted towards night-times (p = 0.001). In NAFLD but not controls, daytime sleepiness significantly correlated with liver enzymes (ALAT [r = 0.44, p = 0.0029], ASAT [r = 0.46, p = 0.0017]) and insulin resistance (HOMA-IR [r = 0.5, p = 0.0009]) independent of cirrhosis. In patients with fibrosis, daytime sleepiness correlated with the degree of fibrosis (r = 0.364, p = 0.019). CONCLUSIONS: In NAFLD sleep duration was shortened, sleep onset was delayed and sleep quality poor. Food-intake was shifted towards the night. Daytime sleepiness was positively linked to biochemical and histologic surrogates of disease severity. The data may indicate a role for sleep-wake cycle regulation and timing of food-intake in the pathogenesis of human NAFLD as suggested from murine models. Public Library of Science 2015-11-17 /pmc/articles/PMC4648512/ /pubmed/26576055 http://dx.doi.org/10.1371/journal.pone.0143293 Text en © 2015 Bernsmeier et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Bernsmeier, Christine Weisskopf, Diego M. Pflueger, Marlon O. Mosimann, Jan Campana, Benedetta Terracciano, Luigi Beglinger, Christoph Heim, Markus H. Cajochen, Christian Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls |
title | Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls |
title_full | Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls |
title_fullStr | Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls |
title_full_unstemmed | Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls |
title_short | Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls |
title_sort | sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease: a comparison with healthy controls |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648512/ https://www.ncbi.nlm.nih.gov/pubmed/26576055 http://dx.doi.org/10.1371/journal.pone.0143293 |
work_keys_str_mv | AT bernsmeierchristine sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT weisskopfdiegom sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT pfluegermarlono sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT mosimannjan sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT campanabenedetta sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT terraccianoluigi sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT beglingerchristoph sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT heimmarkush sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols AT cajochenchristian sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols |